Bioluminescence and Fluorescence Optical Animal Imager
Bioluminescence and Fluorescence Optical Animal Imager
批准号:
10419960
负责人:
GUILLERMO MARQUES
金额:
$44.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2023-08-31
关键词:
18 year old3-DimensionalAffectAnimalsAutoimmunityBioluminescenceCellsDetectionDrug Delivery SystemsFluorescenceFundingHIVImageImmune systemImmunotherapyIschemic StrokeLaboratoriesMammary NeoplasmsMusMuscular DystrophiesOpticsPhysiologicalProstate Cancer therapyResearchResearch PersonnelResearch Project GrantsSamplingSystems DevelopmentTimeUnited States National Institutes of HealthVendorantitumor drugbioluminescence imagingcancer therapyflexibilityfluorescence imagingimagerimaging capabilitiesin vivo imaging systeminstrumentmultimodalityoptical imager
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The Perkin Elmer IVIS Spectrum requested is a whole animal optical imager capable of 2D
and 3D fluorescence and bioluminescence imaging. The instrument provides high
throughput (up to 10 mice at a time), high sensitivity (down to single cell detection), and a
physiological platform that keeps the animals anesthetized and warm during imaging. Like
other IVIS instruments, the IVIS Spectrum is calibrated in absolute radiance units, allowing
comparison between samples imaged in different instruments. This instrument will
replace an 18-year-old optical animal imager that is no longer supported by the vendor.
More than 32 laboratories depend on the current instrument, and their research would be
catastrophically affected if the instrument failed. Among those laboratories are the 10 NIH-
funded investigators that are the users in this proposal. Being able to provide these
investigators with the Perkin Elmer IVIS Spectrum animal imager would protect their
current capabilities of bioluminescence and restore the fluorescence imaging capabilities
available in the past. In addition the new instrument has better sensitivity and multimodal
flexibility. The research projects thus enhanced will cover studies of immune system
development and autoimmunity, surveillance of HIV CNS reservoirs, immune therapy of
cancer, anti-tumor drug delivery in mammary and prostate cancer, and therapies for
ischemic stroke and Duschenne’s muscular dystrophy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF AXONAL TRANSPORT OF A BMP SIGNALING ENDOSOME
-
批准号:8170962
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2010
-
负责人:GUILLERMO MARQUES
-
依托单位:
CHARACTERIZATION OF AXONAL TRANSPORT OF A BMP SIGNALING ENDOSOME
-
批准号:7956528
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2009
-
负责人:GUILLERMO MARQUES
-
依托单位:
Trafficking of BMP signals in neurons
-
批准号:7230249
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2006
-
负责人:GUILLERMO MARQUES
-
依托单位:
Trafficking of BMP signals in neurons
-
批准号:7099772
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2006
-
负责人:GUILLERMO MARQUES
-
依托单位:
海外基金